Naresh Tinani loves his job as a perfusionist at a hospital in Saskatchewan’s capital. To him, monitoring patient blood levels, heart beat and body temperature during cardiac surgeries and intensive care is a “privilege” — “the ultimate interaction between human physiology and the mechanics of engineering.” But Tinani has also been on the other side… Read More »
Two of Washington’s most powerful lawmakers told CNBC they believe Congress will strike a coronaviurs relief package, although the timing is still unknown. Congress and the Trump administration have struggled to strike an aid agreement for several days, even as key relief benefits expired. While negotiations continue, markets got a fresh look at employment, with new data… Read More »
Print this page HORSHAM, PA, July 14, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has approved Tremfya (guselkumab) for adult patients with active psoriatic arthritis (PsA), a chronic progressive disease characterized by painful joints and skin inflammation.[1],[2] Tremfya is the first treatment… Read More »
Dr. Scott Gottlieb told CNBC on Friday he believes there continues to be a significant number of unreported coronavirus cases in the U.S., suggesting as many as 1 in 150 people in the country could be infected. “We must have well over 700,000 infections a day, even though we’re only diagnosing about 60,000,” Gottlieb said… Read More »